Chemotherapy of non-small cell lung cancer in the elderly

Lung Cancer

Volumn 38, Issue 3 SUPPL., 2002, Pages 67-70

  Gridelli, Cesare ^a  

^a S G MOSCATI HOSPITAL   (Italy)

Author keywords

Chemotherapy; Elderly patients; Non small cell lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOOXYGENASE 2 INHIBITOR; DOCETAXEL; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; MITOMYCIN C; NAVELBINE; PACLITAXEL; PROTEIN TYROSINE KINASE INHIBITOR; TAXANE DERIVATIVE; VINDESINE;

ARTICLE; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; LUNG NON SMALL CELL CANCER; META ANALYSIS; MULTIMODALITY CANCER THERAPY; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; QUALITY OF LIFE; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0036895215     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0169-5002(02)00273-8     Document Type: Article

References (28)

1. Silverberg E. Cancer statistics. CA J. 38:1988;5-22.
2. Gridelli C., Perrone F., Monfardini S. Lung cancer in the elderly. Eur. J. Cancer. 33:1997;2313-2314.
3. Havlik R.J., Yancik R., Long S., et al. The National Cancer Institute on Aging and the National Cancer Institute SEER. Collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer. 74:(Suppl. 7):1994;2101-2106.
4. Fentiman I.S., Tirelli V., Monfardini S., et al. Cancer in the elderly: why so badly treated? Lancet. 28:1990;1020-1022.
5. Gridelli C. Chemotherapy of advanced non small cell lung cancer in the elderly: an update. Crit. Rev. Oncol. Hematol. 35:2000;219-225.
6. Chemotherapy in non small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br. Med. J. 311:1995;899-909.
7. Keller S.M., Adak S., Wagner H., et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non small cell lung cancer. New Eng. J. Med. 343:2000;1217-1222.
8. Postoperative radiotherapy in non small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trials. Lancet. 352:1998;257-263.
9. Langer C., Scott C., Byhardt R., et al. Effect of advanced age on outcome in Radiation Therapy Oncology Group studies of locally advanced NSCLC. Lung Cancer. 29:(Suppl. 1):2000;119.
10. Colleoni M., Gaion F., Nelli P., et al. Weekly vinorelbine in elderly patients with non small cell lung cancer. Tumori. 80:1994;448-452.
11. Gridelli C., Perrone F., Gallo C., et al. Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non small cell lung cancer. A two-stage phase II study. Eur. J. Cancer. 33:1997;392-397.
12. Veronesi A., Crivellari D., Magri M.D., et al. Vinorelbine treatment of advanced non small cell lung cancer with special emphasis on elderly patients. Eur. J. Cancer. 32A:1996;1809-1811.
13. Effect of vinorelbine on quality of life and survival of elderly patients with advanced non small cell lung cancer. J. Natl. Cancer Inst. 91:1999;66-72.
14. Wilson J., Burkes R.L., Shepherd F.A., et al. Single agent gemcitabine for elderly patients with non small cell lung cancer (NSCLC): a phase II study. Proc. Am. Soc. Clin. Oncol. 19:2000;547a.
15. Ricci S., Antonuzzo A., Galli L., et al. Gemcitabine monotherapy in elderly patients with advanced non small cell lung cancer. A multicenter phase II study. Lung Cancer. 27:2000;75-80.
16. Gridelli C., Cigolari S., Perrone F., et al. Activity and toxicity of gemcitabine and gemcitabine+vinorelbine in advanced non small cell lung cancer elderly patients: a phase II data from Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial. Lung Cancer. 31:2001;277-284.
17. Fidias P., Supko J., Boral A., et al. A phase II clinical and pharmacokinetic study of weekly paclitaxel in elderly patients with non small cell lung cancer. Lung Cancer. 29:(Suppl. 1):2000;119.
18. Hainsworth J.D., Burris H.A., Litchy S., et al. Weekly docetaxel in the treatment of elderly patients with advanced non small cell lung carcinoma. Cancer. 89:2000;328-333.
19. Rinaldi M., De Marinis F., Ardizzoni A., et al. Correlation between age and prognosis in patients with advanced non small cell lung cancer (NSCLC) treated with cisplatin (CDDP) containing chemotherapy: a retrospective multicenter study. Ann. Oncol. 5:(Suppl. 8):1994;58.
20. Kubota K., Hosomura K., Kakinuma R., et al. Cisplatin nephrotoxicity in elderly patients with lung cancer. Proc. Am. Soc. Clin. Oncol. 17:1998;491A.
21. Oshita F., Kurata T., Kasai T., et al. Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ function. Jpn. J. Cancer Res. 86:1995;1198-1202.
22. Soquet P.J., Bombaron P., Brunel-Crova J., et al. Treatment of advanced and disseminated non small cell lung cancer (NSCLC) in elderly patients: results of MIC regimen. Lung Cancer. 18:(Suppl. 1):1997;24.
23. Nguyen B., Sandler A., Denham C. The safety and efficacy of gemcitabine plus cisplatin in the elderly chemonaive NSCLC patients (age ≥70 years) as compared to the those with age <70 years. Proc. Am. Soc. Clin. Oncol. 18:1999;471a.
24. Feliu J., Martin G., Rodriguez-Jaraiz M., et al. Phase II trial of low dose cisplatin plus gemcitabine in elderly patients with advanced non small cell lung cancer. Preliminary results. Proc. Am. Soc. Clin. Oncol. 20:2001;253b.
25. Feliu J., Gomez L.L., Espinosa E., et al. Gemcitabine plus vinorelbine in non small cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin. Cancer. 86:1999;1463-1469.
26. Beretta G.D., Michetti G., Belometti M.O., et al. Gemcitabine plus vinorelbine in elderly or unfit patients with non small cell lung cancer. Br. J. Cancer. 83:2000;573-576.
27. McKay C. III, Hainsworth J., Burris H. III, et al. Weekly docetaxel/gemcitabine in the treatment of elderly patients with advanced non small cell lung cancer: a Minnie Pearl Cancer Research phase II trial. Proc. Am. Soc. Clin. Oncol. 20:2001;260b.
28. Gridelli C., Perrone F., Cigolari S., et al. The MILES (Multicenter Italian Lung Cancer in the Elderly Study) phase 3 trial: gemcitabine+vinorelbine vs vinorelbine and vs gemcitabine in elderly advanced NSCLC patients. Proc. Am. Soc. Clin. Oncol. 20:2001;308a.